Tarriff Scott
- SEC CIK
- 0001469124
No open-market purchases or sales filed in the past year.
Current role at each company
- EGRX Eagle Pharmaceuticals, Inc.10% Owneras of Mar 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tarriff Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 (view filing) | Nov 1-2 | 2 days | Tarriff ScottCEO | SSale | −21.6K | $13.84 | −$299.3K | −3.8%545.4K after | 2 lots10b5-1 |
| Oct 4, 2023 (view filing) | Oct 2-3 | 2 days | Tarriff ScottCEO | SSale | −20.2K | $14.82 | −$300.0K | −3.4%567.1K after | 3 lots10b5-1 |
| May 18, 2023 (view filing) | May 16 | 2 days | Tarriff ScottCEO | SSale | −15.0K | $19.98 | −$299.7K | −2.5%587.3K after | |
| May 15, 2023 (view filing) | May 11-15 | 4 days | Tarriff ScottCEO | SSale | −45.0K | $20.68 | −$930.7K | −2.7%1.59M after | 5 lots |